Table 8 Factors association with length of hospital stay among patients treated for acute UGIB TASH and Y12HMC between September 2022 and September 2023
Variables | Length of Stay | COR | P-value | AOR | P-value | |
|---|---|---|---|---|---|---|
<7 days →=7days | ||||||
Sex | ||||||
Male | 111 | 30 | 1.14(0.56-2.31) | 0.71 | 1.23(0.57-2.67) | 0.59 |
Female | 46 | 12 | 1.00 | 1.00 | ||
Age | ||||||
<=40 | 88 | 25 | 1.29(0.67-3.47) | 0.45 | 1.12(0.93-4.65) | 0.75 |
>40 | 63 | 23 | 1.00 | 1.00 | ||
Smoking | ||||||
Never | 104 | 25 | 1.00 | 1.00 | ||
Yes | 34 | 12 | 1.31(0.43-4.01) | 0.63 | 1.34(0.36-4.98) | 0.67 |
Unknown | 19 | 5 | 0.83(0.30-2.29) | 0.72 | 0.98(0.29-3.24) | 0.97 |
Alcohol intake | ||||||
Never | 95 | 19 | 1.00 | 1.00 | 0.041 | |
Yes | 45 | 19 | 1.22(0.41-3.59) | 0.03 | 1.39(1.38-5.05) | 0.41 |
Unknown | 15 | 6 | 0.57(0.19-1.63) | 0.29 | 0.60(0.18-2.03) | |
Prior PUD | ||||||
Yes | 12 | 5 | 1.82(0.63-5.21) | 0.27 | 1.97(0.63-6.16) | 0.25 |
No | 142 | 40 | 1.00 | |||
Drugs | ||||||
Yes | 24 | 7 | 1.12(0.44-2.76) | 0.04 | 1.46(1.53-3.99) | 0.046 |
No | 127 | 41 | 1.00 | 1.00 | ||
Co morbidity | ||||||
Yes | 51 | 15 | 1.63(0.83-3.19) | 0.15 | 1.95(1.92-4.17) | 0.034 |
No | 106 | 27 | 1.00 | 1.00 | ||
Medical management only | ||||||
Yes | 130 | 37 | 1.84(0.81-4.16) | 0.14 | 3.34(0.67-16.62) | 0.14 |
No | 21 | 11 | ||||
Endoscopic management | ||||||
Band ligation | 22 | 10 | ||||
Not given | 129 | 38 | 1.54(0.67-3.54) | 0.31 | 1.36(0.28-6.56) | 0.70 |
Prior liver disease | ||||||
Yes | 23 | 9 | 1.56(0.52-2.59) | 0.043 | 1.29(1.54-3.05) | 0.046 |
No ki5 | 134 | 33 | 1.00 | |||